Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Share Price Breaks Above 50 Day Moving Average – Time to Sell?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) shares crossed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $9.16 and traded as high as $9.39. Senseonics Holdings, Inc. Common Stock shares last traded at $9.34, with a volume of 998,843 shares.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on SENS shares. Weiss Ratings lowered shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, October 22nd. Mizuho decreased their price target on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 15th. TD Cowen restated a “buy” rating and set a $15.00 price target on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday. Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Finally, Barclays initiated coverage on shares of Senseonics Holdings, Inc. Common Stock in a research note on Wednesday, October 7th. They set an “equal weight” rating and a $10.00 price objective for the company. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Senseonics Holdings, Inc. Common Stock currently has a consensus rating of “Hold” and an average price target of $13.00.

Senseonics Holdings, Inc. Common Stock Trading Down 2.5%

The company has a market capitalization of $397.55 million, a PE ratio of -4.26 and a beta of 1.02. The company has a fifty day simple moving average of $9.19 and a 200-day simple moving average of $7.21. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. The company had revenue of $14.48 million for the quarter. Analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current year.

Insiders Place Their Bets

In other news, Director Douglas Roeder purchased 13,953 shares of the company’s stock in a transaction dated Wednesday, August 19th. The stock was acquired at an average price of $8.98 per share, with a total value of $125,297.94. Following the purchase, the director directly owned 171,191 shares in the company, valued at approximately $1,537,295.18. This represents a 8.87% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 4.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Integrated Wealth Concepts LLC purchased a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth about $36,000. Kestra Advisory Services LLC purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 1st quarter valued at approximately $68,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at approximately $65,000. State of Wyoming acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth approximately $67,000. Finally, Cetera Investment Advisers acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the 1st quarter worth approximately $85,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.